Expedia Group, Inc. Total Cost of Revenue increased by 9.0% to $377.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $357.00M to $377.00M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a -1.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $374.00M | $442.00M | $395.00M | $371.00M | $419.00M | $455.00M | $412.00M | $414.00M | $407.00M | $412.00M | $340.00M | $358.00M | $362.00M | $388.00M | $335.00M | $357.00M | $377.00M | $376.00M | $346.00M | $377.00M |
| QoQ Change | — | +18.2% | -10.6% | -6.1% | +12.9% | +8.6% | -9.5% | +0.5% | -1.7% | +1.2% | -17.5% | +5.3% | +1.1% | +7.2% | -13.7% | +6.6% | +5.6% | -0.3% | -8.0% | +9.0% |
| YoY Change | — | — | — | — | +12.0% | +2.9% | +4.3% | +11.6% | -2.9% | -9.5% | -17.5% | -13.5% | -11.1% | -5.8% | -1.5% | -0.3% | +4.1% | -3.1% | +3.3% | +5.6% |